DermTech initiates search to identify CEO replacement

DermTech said that John Dobak will continue to serve as president, chief executive officer and director until the earlier of the date the Board appoints a successor and September 30, 2023. The Board has initiated a comprehensive search to identify Dr. Dobak’s replacement. "I’m extremely proud of what we’ve accomplished during my 11-year tenure as CEO having built a strong foundation for DermTech," said John Dobak, M.D., CEO, DermTech. "We’ve achieved widespread product adoption, secured broad payer coverage and scaled the organization for the future. I’m looking forward to finding a successor that will carry my vision forward and bring the genomic revolution to dermatologic care. I’d like to thank my team and the board for their dedication and perseverance. I’m excited about DermTech’s bright future." "On behalf of the board, I want to thank John for his valuable contributions to DermTech over the past eleven years," said Matt Posard, DermTech’s chairman. "We are grateful to have John’s continuing leadership and support during the CEO transition."